SCHEMBL20122365

SCHEMBL20122365

CC(C)OC(=O)[C@H](CSC(=O)OCOC(=O)c1ccccc1)NC(=O)C(C)(C)S

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 2/20 0.40
▸ MME P08473 1/20 0.40
▸ ACE2 Q9BYF1 1/20 0.40
▸ ADRB2 P07550 2/20 0.37
▸ ADRB1 P08588 2/20 0.37
▸ ADRB3 P13945 2/20 0.37
▸ PDCD1 Q15116 1/20 0.36
▸ CD274 Q9NZQ7 1/20 0.36
▸ SMN1; SMN2 Q16637 5/20 0.36
▸ NPC1 O15118 4/20 0.36
▸ RAB9A P51151 4/20 0.36
▸ HTT P42858 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ LMNA P02545 2/20 0.36
▸ HTR1A P08908 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ SCN1A P35498 1/20 0.34
▸ SLC6A3 Q01959 1/20 0.34
▸ SCN5A Q14524 1/20 0.34
▸ SCN2A Q99250 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122368 0.91 ACE (0.42) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122588 0.89 ACE (0.48) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122558 0.89 ADRB2 (0.38) ADRB2ADRB1ADRB3PDCD1CD274
SCHEMBL20122366 0.89 ACE (0.41) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122369 0.89 ACE (0.41) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122476 0.88 ACE (0.40) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122478 0.87 KMT2A (0.43) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122367 0.83 SMN1; SMN2 (0.38) ACEMMEACE2ADRB2ADRB1
SCHEMBL20122373 0.82 MME (0.31) ACEMMEACE2
SCHEMBL20122570 0.82 MME (0.31) ACEMMEACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback